R&D expense · 2019–2025

Ginkgo Bioworks R&D expense

$244M−42.5% · FY2025

Ginkgo Bioworks (DNA) reported $244M in R&D expense for fiscal 2025, −42.5% year on year.

$96.3M2019$160M2020$1.1B2021$1.1B2022$581M2023$424M2024$244M2025
Ginkgo Bioworks — R&D expense, 2019–2025
Fiscal yearR&D expenseChangeFiling
FY20252025-12-31$244M−42.5%Open →
FY20242024-12-31$424M−27.0%Open →
FY20232023-12-31$581M−44.8%Open →
FY20222022-12-31$1.1B−8.4%Open →
FY20212021-12-31$1.1B+619.6%Open →
FY20202020-12-31$160M+65.9%Open →
FY20192019-12-31$96.3M—Open →

R&D expense — Research and development expense is what the company charged to R&D in the income statement for the year. Most companies report no R&D at all — the line is absent rather than zero — so this ranking covers the roughly 40% of filers that do.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2025 compound annual growth +16.7%

R&D expense at companies of similar size

Full ranking by R&D expense →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Ginkgo Bioworks R&D expense |url=https://companiesranked.com/en/company/ginkgo-bioworks/research-and-development-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Ginkgo Bioworks R&D expense. CompaniesRanked. https://companiesranked.com/en/company/ginkgo-bioworks/research-and-development-expense

BibTeX

@misc{companiesranked-en-company-ginkgo-bioworks-research-and-development-expense-2026,
  author       = {{CompaniesRanked}},
  title        = {{Ginkgo Bioworks R\&D expense}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/ginkgo-bioworks/research-and-development-expense}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-K · 0001628280-26-012346 · February 26, 2026

{{cite web |title=Ginkgo Bioworks R&D expense — 10-K (0001628280-26-012346) |url=https://www.sec.gov/Archives/edgar/data/1830214/000162828026012346/dna-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Ginkgo Bioworks overview